CONTACT US
INTERNATIONAL
INVESTORS
CAREERS
PHYSICIANS
PATIENT
FIND A PROVIDER
About
Company
About Sensus Healthcare
Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive, and cost-effective treatments for both oncological and non-oncological conditions.
Read More
Patient Advocates
Skin Cancer and SRT – Jeff Goldstein Interview
Keloid Patient Testimonials
Non-Melanoma Skin Cancer Outcomes
More Patient Advocates
FAQ
What is SRT?
We offer a painless, safe and highly effective non-surgical skin cancer treatment that is an alternative to surgery—Superficial Radio Therapy using the SRT-100™.
Go to FAQ
What does SRT treat?
The SRT-100™ is an excellent treatment option for patients with the following conditions: Keloid scars, Basal cell carcinoma, Squamous cell carcinoma, Metatypical carcinoma, Cutaneous appendage carcinoma, Actinic keratosis, Kaposi’s sarcoma.
Go to FAQ
Is SRT right for me?
The SRT-100™ doesn’t harm surrounding or underlying healthy tissue while targeting cancer cells. The SRT-100™ provides excellent cosmetic outcomes and is a great alternative for patients with various co-morbidities.
Go to FAQ
What should I expect?
You should expect the same results as surgery, but with these additional benefits: No pain, No anesthesia, No cutting, No bleeding, No stitching, No scarring, No interruption of lifestyle, No reconstructive surgery
Go to FAQ
Is the SRT-100 safe?
The SRT-100™ is a safe and proven technology that effectively treats non-melanoma skin cancers, keloid scarring, actinic keratosis and Kaposi’s sarcoma. It is utilized by dermatologists and radiation oncologists all over the world because it delivers good patient outcomes.
Go to FAQ
Careers
Sensus – Field Service Engineer
View Career Opportunities
Physicians
About Us
Leadership
Mission & Values
The Sensus Difference
Faq
Domestic Sales
International Sales
Dermatology
SRT Series™
Vision
Plus
100
Oncology
Radiation Oncologist
Hospital Systems
Aesthetics
Silk by Sensus™
DDS™ (WIP)
Sensus Cloud™
Asset Management
Sensus Cloud
Patient Data Storage
Physician Spotlight
SRT Practice Advantage
Sensus Cloud
Patients
Patient Outcomes / Before & After
Case Studies
Alternative to Mohs Surgery
Treatment After Keloid Removal
Basal Cell Carcinoma Treatment
Squamous Cell Carcinoma Treatment
Investors
Corporate Governance Guidelines
Code of Ethics and Business Conduct
Resources
In the News
Press Releases
Clinical Studies
Contact Us
About
Leadership
Mission & Values
The Sensus Difference
FAQ
Domestic Sales
International Sales
Dermatology
SRT Series™
Vision
Plus
100
Oncology
Radiation Oncologist
Hospital Systems
Aesthetics
Silk by Sensus™
DDS™ (WIP)
Sensus Cloud™
Asset Management
Sensus Cloud
Patient Data Storage
About
Company
About Sensus Healthcare
Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive, and cost-effective treatments for both oncological and non-oncological conditions.
Read More
Patient Advocates
Skin Cancer and SRT – Jeff Goldstein Interview
Keloid Patient Testimonials
Non-Melanoma Skin Cancer Outcomes
More Patient Advocates
FAQ
What is SRT?
We offer a painless, safe and highly effective non-surgical skin cancer treatment that is an alternative to surgery—Superficial Radio Therapy using the SRT-100™.
Go to FAQ
What does SRT treat?
The SRT-100™ is an excellent treatment option for patients with the following conditions: Keloid scars, Basal cell carcinoma, Squamous cell carcinoma, Metatypical carcinoma, Cutaneous appendage carcinoma, Actinic keratosis, Kaposi’s sarcoma.
Go to FAQ
Is SRT right for me?
The SRT-100™ doesn’t harm surrounding or underlying healthy tissue while targeting cancer cells. The SRT-100™ provides excellent cosmetic outcomes and is a great alternative for patients with various co-morbidities.
Go to FAQ
What should I expect?
You should expect the same results as surgery, but with these additional benefits: No pain, No anesthesia, No cutting, No bleeding, No stitching, No scarring, No interruption of lifestyle, No reconstructive surgery
Go to FAQ
Is the SRT-100 safe?
The SRT-100™ is a safe and proven technology that effectively treats non-melanoma skin cancers, keloid scarring, actinic keratosis and Kaposi’s sarcoma. It is utilized by dermatologists and radiation oncologists all over the world because it delivers good patient outcomes.
Go to FAQ
Careers
Sensus – Field Service Engineer
View Career Opportunities
Physicians
About Us
Leadership
Mission & Values
The Sensus Difference
Faq
Domestic Sales
International Sales
Dermatology
SRT Series™
Vision
Plus
100
Oncology
Radiation Oncologist
Hospital Systems
Aesthetics
Silk by Sensus™
DDS™ (WIP)
Sensus Cloud™
Asset Management
Sensus Cloud
Patient Data Storage
Physician Spotlight
SRT Practice Advantage
Sensus Cloud
Patients
Patient Outcomes / Before & After
Case Studies
Alternative to Mohs Surgery
Treatment After Keloid Removal
Basal Cell Carcinoma Treatment
Squamous Cell Carcinoma Treatment
Investors
Corporate Governance Guidelines
Code of Ethics and Business Conduct
Resources
In the News
Press Releases
Clinical Studies
Contact Us
March 30, 2022
The SRT-100™ is very effective in treating keloids and boasts a cure rate of 90%.
Post navigation
What is the cure rate of basal and squamous cell skin cancer when treated with the SRT-100™?
How long is a typical treatment?
